Triall

Triall is positioned as a specialized B2B software entity focused on the clinical trial industry, aiming to enhance the integrity and efficiency of medical research. The company was founded by Hadil Es-Sbai and Joost Flach.

The founders' backgrounds are deeply rooted in the life sciences and clinical research sectors. Hadil Es-Sbai has a career in the clinical research industry that started in 2001, with roles including Clinical Research Associate, Study Manager, and Quality Consultant at various pharmaceutical and research organizations. This extensive experience in managing clinical trials directly informs Triall's mission to address persistent industry challenges.

Triall's core business revolves around creating a blockchain-enabled digital ecosystem designed to serve and connect all professionals involved in clinical trials. The company's mission is to foster smarter, safer, and more efficient clinical trials by integrating workflows and ensuring the integrity of research data. Its clients are primarily sponsors of clinical trials, such as pharmaceutical companies and academic institutions, and Contract Research Organizations (CROs) to whom trial-related tasks are often outsourced. The business model involves offering a suite of eClinical solutions and APIs, with revenue generated through payments for software and services within the ecosystem, facilitated by its native utility token, TRL.

The company's flagship product was Verial eTMF, a blockchain-integrated electronic Trial Master File solution that provides verifiable proof of clinical trial data integrity. This product has been used in commercial clinical trials since 2019. Triall's platform is designed to be an interoperable suite of eClinical solutions that support various trial formats, including decentralized and hybrid models, by leveraging web, mobile, and wearable integrations. A key technological differentiator is the use of blockchain to create an immutable audit trail for documents and data, enhancing traceability and reliability. This approach tackles issues like scattered data and inefficient workflows that can cause significant delays and costs in medical innovation. The platform architecture is modular, allowing for the gradual development of applications that address specific industry pain points.

Keywords: clinical trials, blockchain technology, eClinical solutions, data integrity, Contract Research Organization, pharmaceutical industry, clinical development, Trial Master File, audit trail, regulatory compliance, decentralized trials, Hadil Es-Sbai, Verial eTMF, TRL token, medical research software, study management, clinical data management, life sciences, biopharmaceutical services, research data integrity